HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
RVTY
Revvity, Inc.
RVTY's fundamentals are mixed, but it looks expensive: trading at 70x earnings, about twice its usual 38x. Analysts expect earnings growth.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
RVTY Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Stable |
RVTY's profitability and cash flow are currently healthy, and its revenue and balance sheet are stable.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
RVTY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 18x | $40.50 | -74% |
| Forward | 27x | $157 | — |
| Fair | 37x | $84.05 | -46% |
| Expensive | 54x | $121 | -23% |
| Current | 70x | $157 | — |
Historical ranges are pointers, not guarantees.
RVTY's PE is in its expensive range at 70x. If earnings grow as analysts expect, today's price would be 27x next year's earnings, in its fair range.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
RVTY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect RVTY's earnings to grow and its profitability to improve, with its revenue holding steady.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
RVTY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.81 | +158% |
| Q3 2026 | $2.25 | +14% |
| Q2 2026 | $2.09 | -11% |
| Q1 2026 | $2.08 | -11% |
| Q4 2025 | $2.07 | -5.9% |
| Q3 2025 | $1.98 | -6.6% |
| Q2 2025 | $2.35 | +64% |
| Q1 2025 | $2.34 | +86% |
| Q4 2024 | $2.20 | -60% |
RVTY has the edge over HIMS on earnings quality, reporting a profit while its opponent remains loss making.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over RVTY on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
RVTY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $728.9M | +4.3% |
| Q2 2026 | $729.7M | +1.3% |
| Q1 2026 | $711.1M | +7% |
| Q4 2025 | $772.1M | +5.9% |
| Q3 2025 | $698.9M | +2.2% |
| Q2 2025 | $720.3M | +4.1% |
| Q1 2025 | $664.8M | +2.3% |
| Q4 2024 | $729.4M | +4.8% |
RVTY's revenue has grown year over year for nine quarters in a row: $729M last quarter, up 4.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 13% | +1.3 points |
| Q2 2026 | 12% | -0.4 points |
| Q1 2026 | 11% | -0.2 points |
| Q4 2025 | 14% | -1.8 points |
| Q3 2025 | 12% | -2.6 points |
| Q2 2025 | 13% | +0.2 points |
| Q1 2025 | 11% | +4.1 points |
| Q4 2024 | 16% | +5.2 points |
RVTY has the edge over HIMS on profitability, with a higher operating margin.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over RVTY on cash flow, with more consistent year-over-year improvement.
RVTY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $152.4M | +27% |
| Q2 2026 | $180.9M | +57% |
| Q1 2026 | $95.5M | -15% |
| Q4 2025 | $161.8M | +8% |
| Q3 2025 | $120M | -4.4% |
| Q2 2025 | $115.5M | -15% |
| Q1 2025 | $112.2M | -14% |
| Q4 2024 | $149.8M | -13% |
RVTY still generates free cash flow, though less than at its 2021 peak: $590M over the past year.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over RVTY on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
RVTY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +197K shares |
| 1 year | -3.1% | -3.6M shares |
| 3 years | -10% | -12.4M shares |
| 5 years | -2.8% | -3.2M shares |
| Available history | +0.3% | +325K shares |
RVTY has 112M diluted shares, down 3.1% from a year ago, with $271M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $95,000 |
| Q2 2026 | $16M |
| Q1 2026 | $86.5M |
| Q4 2025 | $168.3M |
| Q3 2025 | $205M |
| Q2 2025 | $293.9M |
| Q1 2025 | $153.6M |
| Q4 2024 | $185.2M |
RVTY spent $271M buying back its own shares over the past year, down 68% from the year before.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
RVTY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.6x | Moderate |
| Q2 2026 | 2.8x | Moderate |
| Q1 2026 | 3.0x | Elevated |
| Q4 2025 | 3.0x | Elevated |
| Q3 2025 | 3.0x | Moderate |
| Q2 2025 | 2.8x | Moderate |
| Q1 2025 | 2.6x | Moderate |
| Q4 2024 | 2.6x | Moderate |
RVTY's net debt is about 2.6 years of its operating earnings (EBITDA), down from 3.0 years a year ago.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
RVTY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 74.3 | Overbought |
| Stochastic | 76.5 | Neutral |
RVTY's weekly RSI is 74 (overbought) and its Stochastic is 77 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
RVTY PE vs Healthcare Sector
| Metric | RVTY | Sector median | Relative |
|---|---|---|---|
| PE | 70x | 26x | 170% above |
| PE % | 91 | 29 | 62 pts above |
RVTY is trading at 70x earnings, a 170% premium to the Healthcare sector's median of 26x.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
RVTY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $154.7 | 1.5% above |
| 20 week MA | $134.0 | 17% above |
| 50 week MA | $112.2 | 40% above |
| 100 week MA | $105.9 | 48% above |
| 200 week MA | $110.0 | 43% above |
RVTY has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
RVTY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $97.1 | $139.7 | +44% |
| 2021 | $139.7 | $193.8 | +39% |
| 2022 | $193.8 | $140.6 | -27% |
| 2023 | $140.6 | $109.3 | -22% |
| 2024 | $109.3 | $112.0 | +2.5% |
| 2025 | $112.0 | $96.8 | -14% |
| 2026 YTD | $96.8 | $157.0 | +62% |
RVTY has the edge over HIMS on returns for 2026, with the stronger performance.